Skip to main content
. 2012 Dec 18;5(6):708–713. doi: 10.3980/j.issn.2222-3959.2012.06.11

Table 2. Laboratory values: baseline, 6 and 12 months.

Parameter Time Treated n=70 Control n=70
RBC (×106/µL) Baseline 4.6±0.7 4.5±0.6
6 months 4.5±0.6 4.5±0.8
12 months 4.7±0.5 4.6±0.6
WBC(×103/µL) Baseline 6.1±0.8 6.2±0.5
6 months 6.3±0.7 6.3±0.7
12 months 6.4±0.8 6.3±0.8
PLT(×103/µL) Baseline 232.4±50 230±55.1
6 months 237.3±52.2 232±54.3
12 months 234.2±53 233±55
Hb (g/dL) Baseline 14 ±1.2 14.2±1.28
6 months 13.7±1.1 14±1
12 months 14.1±1.2 14.1±1.2
Ht (%) Baseline 41.7±3.6 41.5±3.1
6 months 40.6±3.4 41±3.1
12 months 41.3±3 41.1±3.4
Fibrinogen(mg/dL) Baseline 293.6±80 294±88.1
6 months 315.4±83.3 299.6± 84.4
12 months 320.4±83 296.6± 87.7
ATIII (%) Baseline 100.6±2.1 100.4±2.8
6 months 100.7±2 100.5±1.4
12 months 100.6±2.2 100.3±2.1
PT (%) Baseline 96.2±3.3 96.1±3
6 months 96.1±3 96.3±3.4
12 months 96.3±3.4 96.2±3
Tot. CholesteroL(mg%) Baseline 210±23.3 204±27
6 months 200±31.1 205±30
12 months 201±28 206±31.1
HDL (mg%) Baseline 60.2±10.1 59±14
6 months 62.2±12.4 60±13.3
12 months 61.1±10.4 60.3±11.1

P >0.05 (Not significant) for all intergroup and intragroup comparison. RBC=red blood cells; WBC=white blood cells; PLT=platelets; Hb=Haemoglobin; Ht=hematocrit; AT III=antithrombin III; PT=protrombin time; HDL=high density lipoprotein.

(x±s)